Pathological complete response of initially unresectable multiple liver metastases achieved using combined peptide receptor radionuclide therapy and somatostatin analogs following pancreatic neuroendocrine tumor resection: a case report
Abstract Background Peptide receptor radionuclide therapy (PRRT) serves as a novel and effective treatment option for somatostatin receptor-positive unresectable liver metastases of pancreatic neuroendocrine tumors (PNETs). However, there are few reported cases of surgical resection for initially un...
Main Authors: | Ryosuke Umino, Satoshi Nara, Noritoshi Kobayashi, Takahiro Mizui, Takeshi Takamoto, Daisuke Ban, Minoru Esaki, Nobuyoshi Hiraoka, Kazuaki Shimada |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2024-02-01
|
Series: | Surgical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40792-024-01839-4 |
Similar Items
-
Finding the Appropriate Therapeutic Strategy in Patients with Neuroendocrine Tumors of the Pancreas: Guideline Recommendations Meet the Clinical Reality
by: Sebastian Krug, et al.
Published: (2021-07-01) -
Radiolabeled Somatostatin Analogues for Diagnosis and Treatment of Neuroendocrine Tumors
by: Valentina Ambrosini, et al.
Published: (2022-02-01) -
Utility of Somatostatin Receptors in Gastrointestinal Tract and Pancreas Neuroendocrine Tumors
by: Kivilcim Eren ERDOGAN, et al.
Published: (2020-12-01) -
Advances in Molecular Imaging and Radionuclide Therapy of Neuroendocrine Tumors
by: Anna Yordanova, et al.
Published: (2020-11-01) -
Early Complications of Radioisotope Therapy with Lutetium-177 and Yttrium-90 in Patients with Neuroendocrine Neoplasms—A Preliminary Study
by: Barbara Bober, et al.
Published: (2022-02-01)